北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学精神卫生研究所  > 期刊论文
学科主题: 精神卫生
题名:
Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
作者: Zhang, Hongyan1; Li, Huafang2; Shu, Liang1; Gu, Niufan2; Wang, Gang3; Weng, Yongzhen3; Xie, Shiping4; Zhang, Xinbao4; Li, Ting5; Ma, Cui5; Yu, Wei6; Parsons, Bruce7; Schou, Manjula8
关键词: ziprasidone ; risperidone ; schizophrenia
刊名: NEUROPSYCHIATRIC DISEASE AND TREATMENT
发表日期: 2011
DOI: 10.2147/NDT.S16664
卷: 7, 页:77-85
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Clinical Neurology ; Psychiatry
研究领域[WOS]: Neurosciences & Neurology ; Psychiatry
关键词[WOS]: PLACEBO-CONTROLLED TRIAL ; SCHIZOAFFECTIVE DISORDER ; NEUROLEPTIC DOSAGE ; HALOPERIDOL ; EFFICACY ; MULTICENTER ; TOLERABILITY ; OLANZAPINE ; CLOZAPINE ; INPATIENTS
英文摘要:

Background: The aim of the study was to evaluate the efficacy and safety of ziprasidone versus risperidone in Chinese subjects with acute exacerbation of schizophrenia.

Methods: In patients meeting the Chinese Classification of Mental Disorders criteria for schizophrenia and with a Positive and Negative Syndrome Scale (PANSS) total score >= 60 were randomly assigned to six weeks of double-blind treatment with ziprasidone 40-80 mg twice daily or risperidone 1-3 mg bid, flexibly dosed. Noninferiority was demonstrated if the upper limit of the two-sided 95% confidence interval (CI) for the difference in PANSS total score improvement from baseline in the evaluable population was smaller than the prespecified noninferiority margin of 10 units.

Results: The intent-to-treat population comprised 118 ziprasidone-treated and 121 risperidone-treated subjects. Improvement (reduction) from baseline to week 6 in PANSS total score was (-35.6 [95% CI: -38.6, -32.6]) for ziprasidone and (-37.1 [95% CI: -39.9, -34.4]) for risperidone. Noninferiority was demonstrated in the evaluable population with a difference score of 1.5 [95% CI: -2.5, 5.5]. Mean prolactin levels decreased at week 6 compared with baseline for ziprasidone (-3.5 ng/mL), but significantly increased for risperidone (61.1 ng/mL; P < 0.001). More risperidone-treated subjects (14.9%) than ziprasidone-treated subjects (4.2%) reported weight gain >= 7%. Akathisia and somnolence in the ziprasidone group and akathisia and insomnia in the risperidone group were the most common side effects. Treatment-related/treatment-emergent adverse events were reported by 79.7% and 71.1% of ziprasidone-treated and risperidone-treated subjects, respectively.

Conclusion: In Chinese subjects, ziprasidone was as effective as risperidone, with less weight gain and less prolactin elevation.

语种: 英语
项目资助者: Pfizer Inc.
WOS记录号: WOS:000294955100009
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/49922
Appears in Collections:北京大学精神卫生研究所_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Dept Psychiat, Inst Mental Hlth, Beijing 100191, Peoples R China
2.Shanghai Mental Hlth Ctr, Shanghai, Peoples R China
3.Capital Med Univ, Beijing An Ding Hosp, Beijing, Peoples R China
4.Nanjing Brain Hosp, Nanjing, Peoples R China
5.Guangzhou Brain Hosp, Guangzhou, Guangdong, Peoples R China
6.Pfizer China, Beijing, Peoples R China
7.Pfizer Inc, New York, NY USA
8.Pfizer Australia, Sydney, NSW, Australia

Recommended Citation:
Zhang, Hongyan,Li, Huafang,Shu, Liang,et al. Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia[J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT,2011,7:77-85.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhang, Hongyan]'s Articles
[Li, Huafang]'s Articles
[Shu, Liang]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhang, Hongyan]‘s Articles
[Li, Huafang]‘s Articles
[Shu, Liang]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace